AAIPharma Gains EU GMP Certification

AAIPharma received certification from Sweden’s Medical Products Agency (MPA) for EU Good Manufacturing Practice (GMP) compliance of its Wilmington, NC operations. The company’s tablet, capsule and other solid dose drug manufacturing and testing operations are now certified as meeting EU GMPs, allowing the Wilmington plant to produce these products for shipment to countries in Europe.  
    
AAIPharma’s sterile manufacturing operations in Charleston, SC also passed an FDA inspection and gained EU GMP certification.
    
“Certification of our Wilmington operations in addition to the approval of our Charleston manufacturing plant by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in January, is a testament to AAIPharma’s goal to provide high quality pharmaceutical contract manufacturing services to the global market,” stated Lee Karras, senior vice president of Global Pharmaceutical Services at AAIPharma.